Review Note
Last Update: 07/28/2024 06:33 PM
Current Deck: Block I::Quiz 2::Week 3::i. Tyrosine Kinase Receptors
Published
Fields:
Text
{{c1::Tocilizumab}} and {{c1::sarilumab}} and {{c1::humira}} are antibodies to cytokine ligands that play a role in TK-AR signaling pathways thus they are often used to treat autoimmune/inflammatory diseases
Extra
Source
Image
Pronunciation
Suggested Changes:
Deck Changes (Suggestion to move the Note to the following Deck):
Field Changes:
Tag Changes: